Drug-coated balloons reduce the need for permanent heart stents
A new sub-study suggests that using a sirolimus-eluting balloon (SEB), a drug-coated balloon, can reduce the number of stents a patient may need, making it a safe and effective way to treat certain...
View ArticleMilken Institute and Ann Theodore Foundation fund mTOR inhibitor trial for...
The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), has launched a new funding program to support a...
View ArticleSirolimus-eluting balloon emerges as a safe and effective option for coronary...
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis (ISR) undergoing repeated percutaneous coronary intervention (PCI).
View ArticleLandmark trial shows drug-eluting balloon as effective option for in-stent...
Results from the first randomized clinical trial in the United States to compare a sirolimus-eluting balloon (DEB) to control group consisting of drug-eluting stent (DES) and balloon angioplasty (BA)...
View ArticleSirolimus-eluting balloon strategy matches drug-eluting stents in large...
New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates found that utilizing a strategy of sirolimus-eluting balloons with bailout...
View ArticleKey triggers for food allergies in children after organ transplants
Study reviews transplant-acquired food allergies, focusing on pediatric patients, particularly liver transplant recipients. It explores immune system dysfunction, immunosuppressive agents, and gut...
View ArticleTCT 2024 to feature latest advances in interventional cardiovascular medicine
The Cardiovascular Research Foundation is pleased to announce the late-breaking clinical trials and science to be featured at TCT 2024.
View ArticleNovel drug combination shows promise for treating advanced skin cancers in...
People who have had a kidney transplant are at high risk for developing skin cancers. New research directed by investigators from the Johns Hopkins Kimmel Cancer Center is exploring the best...
View ArticleScientists identify a new approach to treating sarcoidosis
A research team led by Georg Stary (Medical University of Vienna and CeMM) has identified a new approach to treating the inflammatory disease sarcoidosis.
View Article3D nanomatrix vascular sheet model for high-throughput atherosclerosis drug...
A groundbreaking 3D, three-layer nanomatrix vascular sheet that possesses multiple features of atherosclerosis has been applied for developing a high-throughput functional assay of drug candidates to...
View ArticleDiscovery of two new enzymes offers easier ways to study and manufacture...
Slumbering among thousands of bacterial strains in a collection of natural specimens at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, several fragile vials held...
View ArticleRice engineers develop split gene-editing tool with enhanced control
To make a gene-editing tool more precise and easier to control, Rice University engineers split it into two pieces that only come back together when a third small molecule is added.
View ArticleUC researchers discover treatment for a rare cancer-like lung disease in women
A treatment for a rare cancer-like lung disease found in women of childbearing age may have been discovered by University of Cincinnati researchers.
View ArticleRapamycin and other rapalogs have potential to delay cancer
A new research perspective was published in Oncotarget's Volume 14 on April 14, 2023, entitled, "Cancer prevention with rapamycin."
View ArticleDoes nirmatrelvir and ritonavir reduce the risk of hospitalization or death...
Researchers investigated the efficacy of ritonavir and nirmatrelvir combination treatment in reducing the risk of COVID-19 severity outcomes such as hospital admissions and deaths when administered...
View ArticleResults from Phase 0/1 trial of ribociclib plus everolimus in patients with...
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, announced results from their Phase 0/1 clinical trial of...
View ArticleResearch uncovers test to identify iMCD patients with superior response to...
New research has uncovered a precision medicine test using blood proteins to identify a novel patient subgroup of idiopathic multicentric Castleman disease (iMCD), a rare blood disorder, who are more...
View ArticleStudy explores therapeutic potential of exploiting autophagy cascade against...
Researchers recently reviewed current knowledge on links between autophagy and coronaviruses and how this knowledge can be used to repurpose autophagy modulators as potential treatment options for...
View ArticleUC study tests efficacy of immune regulating drug in treating patients with...
Researchers at the University of Cincinnati are testing a commonly used drug, called sirolimus, to determine its safety and efficacy in treating hospitalized patients with COVID-19 pneumonia in the trial.
View ArticleScientist proposes geroprotective strategies to reduce lethality of COVID-19...
The Biogerontology Research Foundation, a registered UK charity supporting and promoting aging and longevity research worldwide since 2008, today announced the publication of a paper titled...
View Article
/pic9814888.png)
/fit-in/580x348/filters:format(webp)/english-betterindia/media/media_files/2026/09/17/balaghat-3-2026-09-17-18-46-40.png)
